Evofem Biosciences DSO Ratio 2011-2026 | EVFM

Annual DSO Ratio Evofem Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
202	147	68.8	82.1	166	1.08 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.08 K	68.8	291

Quarterly DSO Ratio Evofem Biosciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
86.3	57.5	593	-	102	97.9	127	-	103	234	67	-	144	88.6	117	-	190	148	164	-	350	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
593	57.5	167

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Amgen AMGN	81.2	$ 345.82	1.71 %	$ 186 B	USA
Amneal Pharmaceuticals AMRX	55.7	$ 12.61	2.35 %	$ 3.95 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	106	$ 24.35	4.64 %	$ 3.1 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.44	5.51 %	$ 383 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	2.39 %	$ 9.26 B	Australia
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	150	$ 2.74	6.42 %	$ 17.2 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.07	1.32 %	$ 6.68 B	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Cerus Corporation CERS	47	$ 1.94	5.43 %	$ 370 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Coherus BioSciences CHRS	559	$ 1.68	0.6 %	$ 197 M	USA